Interventional Cardiology Devices And Equipment Market Size and Forecast 2024-2033|GE Healthcare, Abbott Laboratories, Boston Scientific Corporation, Medtronic Inc., Johnson & Johnson

Overview and Scope

Interventional cardiology devices and equipment are used in interventional cardiology, a branch of medicine that deals with the catheter-based treatment of structural heart diseases.

Sizing and Forecast

The interventional cardiology devices and equipment market size has grown strongly in recent years. It will grow from <b>$14.1 billion in 2023 to $15.48 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. </b> The growth in the historic period can be attributed to cardiovascular disease prevalence, aging population, patient demand for minimally invasive procedures, clinical guidelines and research.

The interventional cardiology devices and equipment market size is expected to see strong growth in the next few years. It will grow to <b>$21.73 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. </b> The growth in the forecast period can be attributed to personalized medicine, telehealth integration, global access to healthcare, robot-assisted interventions. Major trends in the forecast period include advanced imaging technologies, artificial intelligence (ai) in interventional cardiology, complex lesion treatments, next-generation drug-eluting stents (des).

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/interventional-cardiology-devices-and-equipment-global-market-report

Segmentation & Regional Insights

The interventional cardiology devices and equipment market covered in this report is segmented –

1) By Type: Angioplasty Balloons, Angioplasty Stents, Catheters, Plaque Modification Devices, Other Interventional Cardiology Devices

2) By Age Group: New-born (0-30 days), Infant (31 days-1 year), Children (1-18 years), Adult (18+ years)

3) By Application: Hospitals, Clinics, Cardiac Catheterization Labs, Ambulatory Surgical Centers

<b>North America</b> was the largest region in the global interventional cardiology devices and equipment market in 2023. <b>Western Europe</b> was the second-largest region in the interventional cardiology devices and equipment market. The regions covered in the interventional cardiology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2444&type=smp

Major Driver Impacting Market Growth

The interventional cardiology devices and equipment market is being driven by an increase in cardiovascular diseases. Cardiovascular diseases are health problems that are associated with the blood vessels, circulatory system as well as heart. The rise in cardiovascular diseases has led to a rise in healthcare expenditure in the medical equipment market which further drives the interventional cardiac devices and equipment market. According to an estimate by Centers for Disease Control and Prevention (CDC), heart diseases caused 697,000 deaths in 2020. Further, according to an estimate by WHO, cardiovascular diseases are expected to account for 23.6 million deaths by 2030.

Key Industry Players

Major companies operating in the interventional cardiology devices and equipment market include <b> GE Healthcare, Abbott Laboratories, Boston Scientific Corporation, Medtronic Inc., Johnson & Johnson, B. Braun Melsungen AG, Biosensors International Ltd, Novacam Technologies Inc., Cook Medical LLC, Biotronik SE & Co. KG, ACIST Medical Systems Inc., Cordis Corporation, Terumo Corporation, Edward Lifesciences Corporation, Cardinal Health Inc., iVascular GmbH, Becton Dickinson and Company, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Asahi Intecc Co. Ltd., AngioDynamics, C. R. Bard Inc., Endologix Inc., Lombard Medical Limited, Spectranetics Corporation, Vascular Solutions Inc., W. L. Gore & Associates Inc., Cardiva Medical Inc., Cardiovascular Systems Inc., ClearStream Technologies Ltd., Contego Medical LLC, Shockwave Medical Inc. </b>

The interventional cardiology devices and equipment market report table of contents includes:

1. Executive Summary

2. Interventional Cardiology Devices And Equipment Market Characteristics

3. Interventional Cardiology Devices And Equipment Market Trends And Strategies

4. Interventional Cardiology Devices And Equipment Market – Macro Economic Scenario

5. Global Interventional Cardiology Devices And Equipment Market Size and Growth

.

.

.

26. South America Interventional Cardiology Devices And Equipment Market

27. Brazil Interventional Cardiology Devices And Equipment Market

28. Middle East Interventional Cardiology Devices And Equipment Market

29. Africa Interventional Cardiology Devices And Equipment Market

30. Interventional Cardiology Devices And Equipment Market Competitive Landscape And Company Profiles

Top Major Players:

  • GE Healthcare
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic Inc
  • Johnson & Johnson

Explore the trending research reports from TBRC:

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model